Is Vitamin B12 Good for Arthritis Pain and Symptoms?

Vitamin B12 shows some genuine promise for easing arthritis pain, but mostly as a supporting player alongside standard painkillers rather than a standalone treatment. Several small clinical trials have found that B vitamins, including B12, can boost the pain-relieving effect of common anti-inflammatory drugs in osteoarthritis, and lab research hints at anti-inflammatory properties that could matter in rheumatoid arthritis. The picture is more nuanced than supplement marketing would suggest, though, and the quality of evidence varies sharply depending on which type of arthritis you’re dealing with.

What the Osteoarthritis Research Actually Shows

The strongest human evidence for B12 and arthritis pain comes from osteoarthritis of the knee, and even there, the studies are small. In one trial comparing B vitamins, vitamin E, and the NSAID diclofenac head-to-head, patients taking B vitamins saw a greater drop in knee pain scores and overall pain severity than those taking diclofenac alone.¹ A separate double-blind trial of 73 patients found that adding a B vitamin supplement to diclofenac produced bigger improvements in overall pain severity, joint stiffness, and physical function compared to diclofenac with a placebo, though interestingly, the drop in knee pain itself was similar in both groups.²

A third trial took a slightly different approach, giving patients with severe osteoarthritis (who were already scheduled for knee replacement surgery) a single injection of diclofenac combined with thiamine, pyridoxine, and cyanocobalamin. The combination produced better pain relief over 12 hours than diclofenac alone, and patients rated their overall pain perception more favorably.³ These results are encouraging but come with a major caveat: all three trials used B vitamin mixtures (B1, B6, and B12 together), so isolating B12’s individual contribution is difficult. The synergy between B vitamins appears to matter, and researchers studying pain relief tend to test them as a group rather than singling out B12.

Rheumatoid Arthritis Tells a Different Story

If you have rheumatoid arthritis, the evidence for B12 is thinner and more conflicting. A 2024 lab study found that hydroxocobalamin, a manufactured form of B12, significantly reduced the severity of antibody-induced arthritis in mice and lowered expression of several key inflammatory molecules including TNF-alpha, IL-6, and COX-II.⁴ That’s a genuinely interesting finding, because those inflammatory molecules are the same ones targeted by expensive biologic drugs used in RA treatment. But mouse models of arthritis don’t always translate to humans.

On the human side, a study measuring blood levels of B12, vitamin D, and ferritin in RA patients found no correlation between any of those nutrients and disease activity scores.⁵ In other words, patients with higher B12 levels didn’t have milder disease. That doesn’t necessarily mean supplementation can’t help with symptoms, since blood levels and therapeutic doses are different questions, but it does pour cold water on the idea that B12 is a major driver of RA outcomes.

How B12 Could Influence Joint Pain

B12 doesn’t work like a traditional painkiller. It doesn’t block pain the way ibuprofen does. Instead, several biological pathways could explain why it seems to help some people with arthritis pain.

The most established pathway involves homocysteine, an amino acid that your body normally keeps in check using B12 and folate. When B12 is low, homocysteine levels rise. Elevated homocysteine appears to damage cartilage cells by promoting cell death and oxidative stress, and it disrupts the balance between bone formation and bone breakdown in the layer of bone directly beneath cartilage. A Mendelian randomization study (a genetic method of inferring cause and effect) found evidence that this homocysteine-cartilage link may be causal rather than coincidental.⁶ Keeping homocysteine down by maintaining adequate B12 could, in theory, slow some of the joint damage that makes osteoarthritis painful.

B12 also appears to have direct effects on nerve function that could dampen pain signaling. Methylcobalamin, the active form of B12 used in nerve tissue, promotes regeneration of damaged nerves and protects against a type of nerve toxicity that amplifies pain signals.⁷ In animal studies, it reduced pain sensitivity by calming overactive nerve cells in the dorsal root ganglia, the nerve clusters that relay pain signals from your limbs to your spinal cord.⁸ This matters for arthritis because chronic joint inflammation can sensitize nearby nerves, making even ordinary pressure feel painful. If B12 helps reset that nerve sensitivity, it could reduce pain independently of any effect on the joint itself.

The Anti-Inflammatory Angle

Beyond nerves and homocysteine, there’s growing interest in whether B12 directly tamps down inflammation. A study of people at high cardiovascular risk found that higher circulating B12 was linked to lower levels of IL-6 and C-reactive protein, two of the main inflammatory markers that also run high in arthritis. That association held up in naturally aged mice as well.⁹ The relationship isn’t universal, though. A study in adolescents with anxiety or depression found no link between B12 levels and those same inflammatory markers, suggesting the anti-inflammatory association may depend on age, health status, or the presence of an existing inflammatory condition.¹⁰

For arthritis patients specifically, this could be relevant because chronic low-grade inflammation is what drives joint damage over time. If B12 can meaningfully lower IL-6 or CRP in someone whose levels are already elevated from arthritis, that would address part of the disease process, not just the symptoms. But “associated with lower levels” is not the same as “supplementation will lower your levels,” and no randomized trial has yet tested whether B12 supplementation reduces inflammatory markers specifically in arthritis patients.

Can B12 Help You Use Fewer Painkillers?

One of the most practical angles in this research isn’t about replacing anti-inflammatory drugs but about making them work better and faster so you can stop taking them sooner. A meta-analysis and systematic review found that combining B vitamins with NSAIDs can cut the duration of treatment roughly in half compared to NSAIDs alone for certain types of musculoskeletal pain. Shorter treatment courses mean fewer opportunities for the gastrointestinal, kidney, and cardiovascular side effects that make long-term NSAID use risky.¹¹

This NSAID-sparing effect aligns with what the osteoarthritis injection trial found: diclofenac plus B vitamins outperformed diclofenac alone within 12 hours.³ If you’re someone who relies on daily anti-inflammatories for joint pain and worries about long-term side effects, the idea that adding an inexpensive B vitamin supplement might let you take fewer pills is genuinely appealing. Still, these studies mostly looked at acute pain episodes and short treatment courses. Whether the combination works for the kind of chronic, everyday joint pain that defines life with arthritis hasn’t been studied as rigorously.

B12 Deficiency Is Surprisingly Common in Arthritis Patients

Even if B12 supplementation doesn’t turn out to be a game-changer for arthritis symptoms, there’s a separate practical reason to pay attention to your B12 levels if you have an inflammatory joint disease. A study of patients with rheumatoid arthritis, psoriatic arthritis, and lupus found that about a quarter had low serum B12 levels.¹² That said, the researchers found that only about a quarter of those with low readings actually had true functional deficiency when tested more carefully, so low serum numbers don’t always mean your body is running short.

Medications matter here too. Methotrexate, one of the most commonly prescribed drugs for RA, works by interfering with folate metabolism. A study found that nearly three-quarters of RA patients taking methotrexate with folic acid had elevated homocysteine levels, compared to just over half of RA patients on other treatments.¹³ Elevated homocysteine is a sign that your body isn’t methylating properly, and B12 is one of the key players in that process. If you’re on methotrexate, it’s worth discussing B12 status with your rheumatologist, not because it will necessarily ease your arthritis, but because the medication may be disrupting a pathway where B12 is essential.

There’s also an autoimmune angle. Pernicious anemia, an autoimmune condition that prevents B12 absorption, appears alongside other autoimmune diseases more often than chance would predict. A case series from rheumatology clinics identified pernicious anemia antibodies in patients across a range of autoimmune conditions including RA, lupus, Sjogren’s syndrome, and even gout.¹⁴ If you have one autoimmune disease, your risk of developing another is elevated, and undiagnosed B12 deficiency from pernicious anemia can cause numbness, tingling, and weakness that mimic or worsen arthritis symptoms.

What About Gout?

Gout is a form of arthritis driven by uric acid crystal buildup in joints, and B12 may have a distinct role here. A Mendelian randomization study found a negative association between genetically predicted B12 levels and urate (the precursor to uric acid crystals), suggesting that higher B12 may contribute to lower urate levels in the blood.¹⁵ This type of study uses genetic variants as natural experiments, which gives it some advantage over simple observational data in inferring causation. The effect size was modest, though, and no clinical trial has tested whether B12 supplementation actually prevents gout flares. If your urate levels are already well-managed with medication, B12 is unlikely to add much. But for people with borderline levels who are trying to reduce their risk through diet and lifestyle, adequate B12 intake may be one small piece of the puzzle.

The Gut Microbiome Connection

An emerging area of arthritis research involves the gut microbiome, and B12 keeps surfacing in that conversation. A study using genomic sequencing of gut bacteria in patients with different types of inflammatory arthritis found that vitamin B salvage and biosynthesis pathways were among the metabolic processes that differed between patients and healthy controls.¹⁶ In plain terms, the gut bacteria of people with inflammatory arthritis handle B vitamins differently than those of healthy people.

What this means practically is still unclear. It could be that altered gut bacteria in arthritis patients produce or consume B vitamins at unusual rates, potentially contributing to the relatively high rates of low B12 seen in these populations. Or the causality could run the other direction, with inflammation changing the gut environment in ways that shift bacterial metabolism. Researchers are still untangling which comes first. But the finding does suggest that B12’s role in arthritis might extend beyond what you put in your mouth, touching on how your body processes and distributes the vitamin internally.

Safety and What to Consider Before Supplementing

One of B12’s biggest advantages as a potential add-on for arthritis is its safety profile. Unlike NSAIDs or steroids, B12 has very few side effects even at high doses, because it’s water-soluble and your kidneys simply flush out what you don’t need. A review of B12 as a pain treatment concluded that given its low risk of side effects, it could reasonably be considered as an additional tool for pain management.¹⁷

That said, “safe” and “effective” are different questions. The research consistently shows that B12 works best in combination with other B vitamins and alongside conventional painkillers, not as a replacement. If you’re considering B12 for arthritis, a few practical points are worth keeping in mind:

• Form matters somewhat: Methylcobalamin is the form with the most research behind its nerve-protective and pain-modulating effects. Cyanocobalamin is cheaper and more stable but needs to be converted in the body. Either will correct a deficiency, but for pain-specific purposes, the research leans toward methylcobalamin.
• Get tested first: If you have inflammatory arthritis, ask your doctor to check your B12 and homocysteine levels. Correcting an actual deficiency can resolve symptoms like fatigue, numbness, and tingling that may be compounding your joint pain.
• Injections vs. pills: Most arthritis-related trials used injections, which bypass absorption issues. If you have pernicious anemia or gastrointestinal problems, oral supplements may not raise your levels adequately.
• Don’t stop your other medications: No study suggests that B12 can replace disease-modifying drugs for RA or standard treatment for OA. The evidence supports it as something you add, not something you swap in.

Why the Evidence Stays Frustratingly Small

If B12 looks this promising in small trials, why hasn’t a large definitive study settled the question? Part of the answer is economic. B12 is a cheap, unpatentable vitamin with no pharmaceutical company standing to profit from a large trial. The studies that do exist have been conducted mostly by academic researchers with limited budgets, which is why you see sample sizes of 48 or 73 patients instead of thousands. Another factor is that B12 is almost always tested as part of a B vitamin complex (B1, B6, and B12 together), making it hard to isolate B12’s specific contribution. Researchers studying pain tend to care about whether the combination works, not about parsing which vitamin deserves credit.

There’s also a design problem. Arthritis is chronic, but most of the existing trials measured outcomes over days to weeks. Osteoarthritis progresses over years, and the homocysteine-cartilage pathway that makes B12 theoretically interesting would take a long time to manifest as measurable joint preservation. A trial that truly tested whether B12 slows osteoarthritis progression would need to follow patients for years with repeated imaging, an expensive proposition for a vitamin supplement study. Until that kind of research happens, we’re left with evidence that B12 can help with pain in the short term, especially alongside NSAIDs, but without knowing whether it changes the long-term trajectory of the disease.